文献速递瘢痕与激光

肥厚性瘢痕与瘢痕疙瘩治疗和预防的最新算法:对10年前发表算法的2020年更新

The Most Current Algorithms for the Treatment and Prevention of Hypertrophic Scars and Keloids: A 2020 Update of the Algorithms Published 10 Years Ago.
PubMed 文献 · Plast Reconstr Surg · 2022-01-01

本文是对2010年发表的肥厚性瘢痕和瘢痕疙瘩文献综述的更新,纳入了十年间新增的随机对照试验等研究。文章总结了促进瘢痕生长的局部、全身、遗传和生活方式危险因素,并依据瘢痕挛缩严重程度及瘢痕疙瘩大小和数量提出了更新的预防与治疗算法。作者指出尽管现有研究存在多种局限性,但瘢痕管理已显著改善,未来高质量试验有望进一步完善当前算法。

要点

  • 肥厚性瘢痕治疗依瘢痕挛缩严重程度:严重者首选手术,不严重者采用保守治疗。
  • 瘢痕疙瘩治疗依大小和数量:小而单发可根治性手术加辅助治疗(如放疗)或多模式保守治疗;大而多发可选择减容减数手术。
  • 无论采用何种治疗,患者均应长期随访;保守治疗包括凝胶片、胶带固定、局部和注射外用制剂、口服药物及化妆疗法,应个体化实施。

核心结论

  • 过去十年关于病理性瘢痕管理的随机对照试验显著增加。
  • 尽管这些研究存在各种局限性,但它们大大改善了肥厚性瘢痕和瘢痕疙瘩的管理。
  • 未来高质量试验可能进一步完善当前的肥厚性瘢痕和瘢痕疙瘩治疗算法。

研究设计与样本

  • 本文为对2010年发表的肥厚性瘢痕和瘢痕疙瘩文献综述的更新。
  • 对所有研究进行了方法学质量评估,提取了患者基线特征、干预措施及其结局。
  • 在可获得的情况下纳入了系统综述、Meta分析和综合综述。

主要发现

  • 促进肥厚性瘢痕和瘢痕疙瘩生长的危险因素包括局部因素(伤口/瘢痕上的张力)、全身因素(如高血压)、遗传因素(如单核苷酸多态性)和生活方式因素。
  • 肥厚性瘢痕的治疗取决于瘢痕挛缩严重程度:如果严重,手术是首选;如果不严重,则采用保守治疗。
  • 瘢痕疙瘩的治疗取决于其是小而单发还是大而多发:小而单发者可根治性手术加辅助治疗(如放疗)或多模式保守治疗;大而多发者减容减数手术是一种选择。

关键数值与推荐

  • 肥厚性瘢痕:严重挛缩者手术首选,非严重者保守治疗。
  • 小而单发瘢痕疙瘩:根治性手术加辅助治疗(如放疗)或多模式保守治疗。
  • 大而多发瘢痕疙瘩:减容减数手术是一种选择。
  • 保守治疗包括凝胶片、胶带固定、局部和注射外用制剂、口服药物及化妆疗法,应个体化实施。
  • 无论采用何种治疗,患者均应长期随访。

临床怎么用

  • 根据瘢痕挛缩严重程度选择肥厚性瘢痕的治疗策略。
  • 根据瘢痕疙瘩的大小和数量选择根治性手术加辅助治疗、多模式保守治疗或减容减数手术。
  • 保守治疗应个体化实施,包括凝胶片、胶带固定、局部和注射外用制剂、口服药物及化妆疗法。
  • 无论采用何种治疗,患者均应长期随访。

局限性

  • 原文指出这些随机对照试验存在各种局限性,但未具体说明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2010, this Journal published my comprehensive review of the literature on hypertrophic scars and keloids. In that article, I presented evidence-based algorithms for the prevention and treatment of these refractory pathologic scars. In the ensuing decade, substantial progress has been made in the field, including many new randomized controlled trials. To reflect this, I have updated my review. METHODS: All studies were evaluated for methodologic quality. Baseline characteristics of patients were extracted along with the interventions and their outcomes. Systematic reviews, meta-analyses, and comprehensive reviews were included if available. RESULTS: Risk factors that promote hypertrophic scar and keloid growth include local factors (tension on the wound/scar), systemic factors (e.g., hypertension), genetic factors (e.g., single-nucleotide polymorphisms), and lifestyle factors. Treatment of hypertrophic scars depends on scar contracture severity: if severe, surgery is the first choice. If not, conservative therapies are indicated. Keloid treatment depends on whether they are small and single or large and multiple. Small and single keloids can be treated radically by surgery with adjuvant therapy (e.g., radiotherapy) or multimodal conservative therapy. For large and multiple keloids, volume- and number-reducing surgery is a choice. Regardless of the treatment(s), patients should be followed up over the long term. Conservative therapies, including gel sheets, tape fixation, topical and injected external agents, oral agents, and makeup therapy, should be administered on a case-by-case basis. CONCLUSIONS: Randomized controlled trials on pathologic scar management have increased markedly over the past decade. Although these studies suffer from various limitations, they have greatly improved hypertrophic scar and keloid management. Future high-quality trials are likely to improve the current hypertrophic scar and keloid treatment algorithms further.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Ogawa R. The Most Current Algorithms for the Treatment and Prevention of Hypertrophic Scars and Keloids: A 2020 Update of the Algorithms Published 10 Years Ago. Plast Reconstr Surg. 2022. PMID: 34813576. doi:10.1097/PRS.0000000000008667

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。